
French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …

Japanese pharma firm Takeda have announced that lung cancer treatment Alunbrig has proven successful in reducing the risk of disease …

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …

The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …

Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …

Scientists at the University of Edinburgh were able to restore a regenerative response that prevented the need for a liver …

Cleveland Clinic researchers have designed a potential new class of drugs that may reduce the risk of cardiovascular disease by …

A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s …

An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …

A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm …

French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and …

With levels of antidepressant prescription rising coupled with the lack of development and investment in new treatments, further research into …

Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …
French drugmaker Sanofi (Euronext: SAN) said it will co-develop a Zika vaccine candidate with the US government. No financial details …

Merck said late-stage trials for its Erbitux (cetuximab) in combination with Folfox significantly improved progression free survival in metastatic colorectal …